Therapy News and Research

RSS

Accelr8 presents initial ICU pilot study results at ATS International Conference

Accelr8 Technology Corporation announced that clinical investigators led by Ivor S. Douglas, MD/FRCP (UK) from Denver Health presented initial ICU pilot study results at the 2011 ATS International Conference.

17 May 2011

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.

17 May 2011

Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC

Pfizer Inc. announced today that its New Drug Application for crizotinib, an oral first-in-class anaplastic lymphoma kinase inhibitor, has been accepted for filing and granted Priority Review status by the U.S. Food and Drug Administration and has been filed with the Japanese Ministry of Health, Labour and Welfare.

17 May 2011

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon technology.

From Medtronic 17 May 2011

Antiretrovirals important to protect HIV-positive children from measles

Scientific American looks at the possible link between HIV prevalence and a recent increase in the number of children dying from measles in sub-Saharan Africa. "Studies show that infants with HIV do not respond well to the measles vaccine even when given a second dose at nine months, as the World Health Organization currently recommends," the article notes.

17 May 2011

Inhalation of hydrogen can reduce hyperoxic lung injury

Inhaling small amounts of hydrogen in addition to concentrated oxygen may help stem the damage to lung tissue that can occur when critically ill patients are given oxygen for long periods of time, according to a rat model study conducted by researchers in Pittsburgh. The study also found hydrogen initiates activation of heme-oxygenase (HO-1), an enzyme that protects lung cells.

17 May 2011

New bronchial thermoplasty long-term safety data in asthma presented at ATS annual meeting

Boston Scientific Corporation today announced long-term safety data from the Research in Severe Asthma (RISA) Trial, which demonstrated the maintenance of stable lung function and the absence of clinical complications over a five-year period in patients with severe refractory asthma treated with its Alair Bronchial Thermoplasty System.

17 May 2011

Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma

Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.

17 May 2011

Accumetrics' VerifyNow P2Y12 Test receives CE mark approval for prognostic use

Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying patients with high residual platelet reactivity on antiplatelet therapy who are at greater risk for future cardiovascular events.

17 May 2011

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S. indicates the agents do not appear to be any more effective than traditional blood thinners for the majority of these patients.

17 May 2011

Virtual reality offers returning soldiers 'psychotherapy by computer' to treat PTSD

For those soldiers worried about the stigma associated with seeing a therapist, virtual reality applications for the treatment of post-traumatic stress disorder (PTSD) may be the alternative to the traditional "talk therapy."

17 May 2011

HealthPartners prescribes walking or exercise for patients with depression

Giving pedometers to patients screened for depression, HealthPartners Medical Group (HPMG) is prescribing walking or exercise in addition to medication and/or therapy as an effective tool in helping patients with depression.

17 May 2011

Miniature, easy-to-carry ventilation system may help patients with COPD become more active

A miniature, easy-to-carry ventilation system with a simple nasal mask may help patients with chronic obstructive pulmonary disease become more active, according to research conducted at medical centers in California and Utah. The compact design offers an attractive alternative to currently available larger, less comfortableventilators and masks.

17 May 2011

Viewpoints: Ryan on 'shared scarcity'; Romney fallout; Baltimore's ambitious health plan

Too many in Washington remain fixated on the next election, at the expense of the next generation. But there is a hidden cost to the shared scarcity mentality — a cost measured in lost prosperity and lost freedom. We face a choice between two futures. We can continue to go down the path toward shared scarcity, or we can choose the path of renewed prosperity.

17 May 2011

FDA nod for hepatitis C drug

Merck & Co have finally won the Food and Drugs Administration – FDA’S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.

17 May 2011

Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients

In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, "The evidence is clearly starting to show that it's much better to treat patients earlier, but from where will the money come?".

17 May 2011

Gene variant linked to infertility in women

A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins researchers suggests.

16 May 2011

Calypso System can precisely deliver radiation in post-prostatectomy patients

Calypso Medical Technologies, Inc., developer of GPS for the Body® technology used for the precise tracking of cancerous tumors during radiation therapy, is exhibiting at the American Urological Association Annual Meeting (booth 4337) and will discuss recent clinical findings suggesting that the Calypso® System can be used to more precisely deliver radiation in post-prostatectomy patients.

16 May 2011

IsoRay third fiscal quarter sales increase 17%

IsoRay Inc., announced financial results for the third fiscal quarter ended March 31, 2011 underscoring significant improvements in quarterly sales revenue growth both sequentially and in the prior year quarter. Sales increased 17% in the period with the Company posting a 581% gain in gross profit compared to the prior year third quarter.

16 May 2011

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Continuous positive airway pressure, or CPAP, can increase alertness and even improve quality of life for sufferers of obstructive sleep apnea, even if their symptoms are minimal, according to a study conducted by researchers in Europe.

16 May 2011

Therapy News and Research

Accelr8 presents initial ICU pilot study results at ATS International Conference

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

Antiretrovirals important to protect HIV-positive children from measles

Inhalation of hydrogen can reduce hyperoxic lung injury

New bronchial thermoplasty long-term safety data in asthma presented at ATS annual meeting

Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma

Accumetrics' VerifyNow P2Y12 Test receives CE mark approval for prognostic use

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Virtual reality offers returning soldiers 'psychotherapy by computer' to treat PTSD

HealthPartners prescribes walking or exercise for patients with depression

Miniature, easy-to-carry ventilation system may help patients with COPD become more active

Viewpoints: Ryan on 'shared scarcity'; Romney fallout; Baltimore's ambitious health plan

FDA nod for hepatitis C drug

Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients

Gene variant linked to infertility in women

Calypso System can precisely deliver radiation in post-prostatectomy patients

IsoRay third fiscal quarter sales increase 17%

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News